Literature DB >> 10147335

Corneal complications of cataract surgery.

W T Green1, M G Muir.   

Abstract

Developments in cataract surgery have stimulated a greater interest in minimizing unwanted effects of cataract surgery on the cornea. The two main areas of concern are protection of the corneal endothelium and minimizing distortion of the anterior corneal surface. Endothelial cell loss is of particular importance where there is a preexisting significantly low cell count due to ocular trauma, surgery, or dystrophy, and in situations where cataract extraction is combined with other procedures that may be prolonged or require extensive manipulation. Recent availability of heavier molecular-weight viscoelastic substances are expected to help in minimizing endothelial cell trauma in these situations. In terms of postoperative corneal astigmatism the emphasis has changed for those who are regularly performing phacoemulsification from minimizing surgically induced astigmatism to planning the procedure so that it incorporates a correction of preexisting astigmatism. This emphasis may be more significant in cases of previous anterior segment surgery or trauma.

Entities:  

Mesh:

Year:  1994        PMID: 10147335     DOI: 10.1097/00055735-199408000-00014

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  3 in total

1.  In vivo confocal microscopic evaluation of keratic precipitates and endothelial morphology in Fuchs' uveitis syndrome.

Authors:  M C Mocan; S Kadayifcilar; M Irkeç
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

2.  Monitoring of central corneal thickness after phacoemulsification-comparison of statical and rotating Scheimpflug pachymetry, and spectral-domain OCT.

Authors:  Daniel M Handzel; Carsten H Meyer; Alfred Wegener
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

3.  The development of in vitro biocompatibility tests for the evaluation of intraocular biomaterials.

Authors:  A W Lloyd; S Dropcova; R G Faragher; P R Gard; G W Hanlon; S V Mikhalovsky; C J Olliff; S P Denyer; E Letko; M Filipec
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.